Judicious Use of Lipid Lowering Agents in the Management of NAFLD

Judicious Use of Lipid Lowering Agents in the Management of NAFLD

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the Western world. NAFLD encompasses a spectrum of histological features, including steatosis, steatohepatitis with balloon degeneration, and hepatic fibrosis leading to cirrhosis. In patients with advance...

Full description

Bibliographic Details
Main Authors: Umair Iqbal, Brandon J. Perumpail, Nimy John, Sandy Sallam, Neha D. Shah, Waiyee Kwong, George Cholankeril, Donghee Kim, Aijaz Ahmed
Format: Article
Language:English
Published: MDPI AG 2018-09-01
Series:Diseases
Subjects:
NAFLD
NASH
hepatic fibrosis
hyperlipidemia
statins
Online Access:http://www.mdpi.com/2079-9721/6/4/87

Similar Items

Similar Items